EGFR and neoplasm: It promotes chromosomal instability and metastasis in breast cancer (45), enhances tumor progression and chemoresistance via Wnt/β-catenin signaling in colorectal cancer (46), and modulates EGFR signaling in pancreatic cancer (47).